Variability in case severity and in the range of symptoms experienced has been apparent from the earliest months of the COVID-19 pandemic. From a clinical perspective, symptom variability might indicate various routes/mechanisms by which infection leads to disease, with different routes requiring potentially different treatment approaches. For public health and control of transmission, symptoms in community cases were the prompt on which action such as PCR testing and isolation was taken. However, interpreting symptoms presents challenges, for instance in balancing sensitivity and specificity of individual symptoms with the need to maximise case finding, whilst managing demand for limited resources such as testing. For both clinical and tra...
BACKGROUND: The COVID-19 pandemic has had an immeasurable impact, affecting healthcare systems, the ...
BACKGROUND: “Classic” symptoms (cough, fever, loss of taste/smell) prompt severe acute respiratory...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
Variability in case severity and in the range of symptoms experienced has been apparent from the ear...
Respiratory viruses that were suppressed through previous lockdowns during the COVID-19 pandemic hav...
Released datasets and code to support paper "Diversity of symptom phenotypes in SARS-CoV-2 community...
Extensive global sampling and sequencing of the pandemic virus severe acute respiratory syndrome cor...
Background: The ongoing pandemic of SARS-COV-2 has already infected more than eight million people w...
Epidemiological and genetic studies on COVID-19 are currently hindered by inconsistent and limited t...
During its first two years, the SARS-CoV-2 pandemic manifested as multiple waves shaped by complex i...
Extensive global sampling and sequencing of the pandemic virus severe acute respiratory syndrome cor...
BACKGROUND: The COVID-19 pandemic has had an immeasurable impact, affecting healthcare systems, the ...
BACKGROUND: “Classic” symptoms (cough, fever, loss of taste/smell) prompt severe acute respiratory...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...
Variability in case severity and in the range of symptoms experienced has been apparent from the ear...
Respiratory viruses that were suppressed through previous lockdowns during the COVID-19 pandemic hav...
Released datasets and code to support paper "Diversity of symptom phenotypes in SARS-CoV-2 community...
Extensive global sampling and sequencing of the pandemic virus severe acute respiratory syndrome cor...
Background: The ongoing pandemic of SARS-COV-2 has already infected more than eight million people w...
Epidemiological and genetic studies on COVID-19 are currently hindered by inconsistent and limited t...
During its first two years, the SARS-CoV-2 pandemic manifested as multiple waves shaped by complex i...
Extensive global sampling and sequencing of the pandemic virus severe acute respiratory syndrome cor...
BACKGROUND: The COVID-19 pandemic has had an immeasurable impact, affecting healthcare systems, the ...
BACKGROUND: “Classic” symptoms (cough, fever, loss of taste/smell) prompt severe acute respiratory...
BACKGROUND: The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We ai...